Skip to content
MMyGLP Reviews
Navigation & orchestrationRank #7 of 12Prescribes

Teladoc Health

Enterprise virtual care with chronic condition management at national scale

Founded 2002 · Purchase, NY · Public · Website

7.4Adequate
Weighted score
Adequate
Reviewed September 19, 2026
PMPM benchmark
$18–$44
Category planning band — not a vendor quote. Excludes drug spend.

Our verdict

The right structural answer for large, complex employers who value control and integration over member delight. Insist on unbundled pricing so you can actually compare it to specialists.

Scorecard

How it scored

Scored against the published rubric. Weights are fixed before review and identical for every vendor.

Clinical rigor7.3

Prescriber credentials, titration protocol, comorbidity screening, and off-ramp planning.

Outcomes evidence7.0

Quality of published results: peer review, sample size, control group, and follow-up duration.

Cost control7.6

Ability to hold net pharmacy spend down: gating, biosimilar strategy, and risk sharing.

Data & reporting8.2

Eligibility-level reporting, claims feeds, and whether you can audit the vendor's own numbers.

Integration9.2

PBM, carrier, HRIS, and point-solution interoperability without custom engineering.

Member experience6.8

Time to first appointment, app quality, care-team continuity, and support responsiveness.

Analysis

What we found

Teladoc's argument is consolidation, and for a large enterprise it is a strong one. It plugs into infrastructure you already run, it lets your policy rather than a vendor's clinical philosophy determine who gets what, and bundling can make the marginal cost of weight management look very attractive. The tradeoff is depth. Members report less continuity and slower access than at specialist vendors, and the product does not evolve at the pace of companies whose entire existence depends on it.

Strengths

  • Integration breadth is unmatched — it already connects to essentially every PBM, carrier, and HRIS you run
  • Eligibility rules are employer-configurable, so your policy governs rather than the vendor's clinical defaults
  • Bundling weight management with existing Teladoc services materially lowers effective PMPM

Limitations

  • Member experience is the weakest in this evaluation — care-team continuity is a persistent complaint
  • Weight management is one line in a broad portfolio and does not get specialist-level product attention
  • 36-month term with 180-day notice is the least flexible commitment here

Best for

Large enterprises already running Teladoc who want policy control and one contract instead of five.

Watch out

Bundled pricing obscures what you actually pay for weight management. Demand the standalone line item before comparing.

The details

Commercial and clinical specifics

The facts you will need to build a comparison grid. Verify each against the vendor's own documentation before contracting.

Pricing

Model
PMPM across the full eligible population, bundled with other Teladoc services
PMPM range
$18–$44
Setup fee
Bundled into enterprise agreement
Medications included
No
Performance guarantees
Standard enterprise SLAs; clinical guarantees negotiable

Contract

Minimum lives
5,000
Term
36 months
Termination notice
180 days

Eligibility

BMI threshold
Configurable by employer
Prior authorization
Yes
Step therapy
Yes
Comorbidity required
No

Clinical model

Prescribes
Yes
Care team
Physicians, Nurse practitioners, Certified diabetes educators, Coaches
Titration protocol
Configurable to employer policy; defaults to conservative escalation
Off-ramp
Chronic-care management continues after weight targets are met
Formulary
Semaglutide, Tirzepatide, Liraglutide, Metformin, Full chronic-care formulary

Outcomes evidence

Headline claim
Condition-level improvement reported across an integrated cardiometabolic population
Evidence level
Vendor-reportedMarketing figure with no published methodology. Treat as a claim, not a result.
Sample size
Not verified in a citation we could confirm
Follow-up
Not verified

Sources

  1. Teladoc Health weight managementWe could not confirm a specific peer-reviewed outcomes citation for the weight-management programme during this review. Rated vendor-reported until one is verified.

Outcomes verified 2026-09-19. Pricing and contract figures on this page are category planning benchmarks, not vendor quotes — see methodology.

Integrations

PBMs
CVS Caremark, Express Scripts, Optum Rx, Prime Therapeutics
Carriers
Aetna, Cigna, UnitedHealthcare, BCBS plans, Kaiser
HRIS
Workday, ADP, UKG, Paycom, Oracle
Eligibility file
834, daily cadence available

Formulary

Teladoc Health by medication

How a vendor positions each molecule reveals more about its cost discipline than any single score. First-line means an eligible member can start immediately; escalation means a documented lower-cost trial comes first.

First-line

Available first-line, but the decisive feature is that eligibility and step-therapy rules are employer-configurable. Your policy governs access here, not Teladoc's clinical defaults — which is the strongest argument for buying it.

Read pairing

Teladoc Health Reviews Tirzepatide

Dual GIP/GLP-1 receptor agonist

First-line

Same configurable posture as semaglutide. For a large employer running multiple point solutions, uniform policy enforcement across both molecules is worth more than any individual clinical feature.

Read pairing
Adjunct

Part of the broader chronic-care formulary and usable as a configured step-therapy rung, though it is not the default pathway.

Read pairing
First-line

Core to the chronic-care model, which predates the weight-management line and covers diabetes management at national scale.

Read pairing

Alternatives

Others in navigation & orchestration

Same category, so these are genuine substitutes rather than different products at different prices.

Compare head to head
7.1

Care orchestration that routes members and enforces benefit policy

Navigation & orchestrationCompanionStep therapy
PMPM benchmark
$12–$32
Minimum lives
5,000
Read evaluation